For example, oral administration of cidomycin increased the small intestine transit rate and lowered serum ALT, AST, and TNF-α levels in NASH rats, suggesting the potential of cidomycin in alleviating the severity of NASH by intervening gut microbiota [158]. Here, GPT is linked to metabolic dysfunction-associated steatohepatitis.